Switch to:
Alexion Pharmaceuticals Inc (NAS:ALXN)
Enterprise Value
$35,855 Mil (As of Today)

Think of enterprise value as the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents.

EV/EBIT ratio is calculated as enterprise value divided by its EBIT. As of today, Alexion Pharmaceuticals Inc's enterprise value is $35,855 Mil. Alexion Pharmaceuticals Inc's operating income for the trailing twelve months (TTM) ended in Sep. 2014 was $803 Mil. Therefore, Alexion Pharmaceuticals Inc's EV/EBIT ratio for today is 44.65.

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Alexion Pharmaceuticals Inc's enterprise value is $35,855 Mil. Alexion Pharmaceuticals Inc's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Sep. 2014 was $845 Mil. Therefore, Alexion Pharmaceuticals Inc's EV/EBITDA ratio for today is 42.44.

EV/Revenue ratio is calculated as enterprise value divided by its Revenue. As of today, Alexion Pharmaceuticals Inc's enterprise value is $35,855 Mil. Alexion Pharmaceuticals Inc's revenue for the trailing twelve months (TTM) ended in Sep. 2014 was $2,076 Mil. Therefore, Alexion Pharmaceuticals Inc's EV/Revenue ratio for today is 17.27.


Definition

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents.

Alexion Pharmaceuticals Inc's Enterprise Value for the fiscal year that ended in Dec. 2013 is calculated as

Enterprise Value (A: Dec. 2013 )
=Market Cap+Preferred Stock+Long-Term Debt
=26172.83264+0+97.23
+Short-Term Debt Without Lease+Minority Interest-Cash and Cash Equivalents
+48+0-1514.851
=24,803

Alexion Pharmaceuticals Inc's Enterprise Value for the quarter that ended in Sep. 2014 is calculated as

Enterprise Value (Q: Sep. 2014 )
=Market Cap+Preferred Stock+Long-Term Debt
=32882.106+0+108.53
+Short-Term Debt Without Lease+Minority Interest-Cash and Cash Equivalents
+48+0-1781.707
=31,257

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of enterprise value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV/EBIT ratio is calculated as enterprise value divided by its EBIT.

Alexion Pharmaceuticals Inc's EV/EBIT for today is

EV/EBIT ratio=Enterprise Value (Today)/Operating Income (TTM)
=35855.023/803.083
=44.65

Alexion Pharmaceuticals Inc's current Enterprise Value is $35,855 Mil.
Alexion Pharmaceuticals Inc's Operating Income for the trailing twelve months (TTM) ended in Sep. 2014 was 138.072 (Dec. 2013 ) + 209.503 (Mar. 2014 ) + 218.849 (Jun. 2014 ) + 236.659 (Sep. 2014 ) = $803 Mil.

2. EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA.

Alexion Pharmaceuticals Inc's EV/EBITDA for today is:

Alexion Pharmaceuticals Inc's current Enterprise Value is $35,855 Mil.
Alexion Pharmaceuticals Inc's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Sep. 2014 was 147.238 (Dec. 2013 ) + 222.242 (Mar. 2014 ) + 229.135 (Jun. 2014 ) + 246.217 (Sep. 2014 ) = $845 Mil.

3. EV/Revenue ratio is calculated as enterprise value divided by its Revenue.

Alexion Pharmaceuticals Inc's EV/Revenue for today is:

EV/Revenue ratio=Enterprise Value (Today)/Revenue (TTM)
=35855.023/2076.166
=17.27

Alexion Pharmaceuticals Inc's current Enterprise Value is $35,855 Mil.
Alexion Pharmaceuticals Inc's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Sep. 2014 was 441.909 (Dec. 2013 ) + 566.616 (Mar. 2014 ) + 512.495 (Jun. 2014 ) + 555.146 (Sep. 2014 ) = $2,076 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Related Terms

Market Cap, Preferred Stock, Long-Term Debt, Cash and Cash Equivalents


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Alexion Pharmaceuticals Inc Annual Data

Jul04Jul05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
ev 2086871,2462,9102,8264,1797,01312,72417,41024,803

Alexion Pharmaceuticals Inc Quarterly Data

Jun12Sep12Dec12Mar13Jun13Sep13Dec13Mar14Jun14Sep14
ev 18,57421,48717,41017,09917,03321,60524,80328,72729,46931,257
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK